These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 15171020)

  • 1. [Relapses in pulmonary tuberculosis. Value of the case history for the selection of the best retreatment regimen].
    Pilheu JA; de Salvo MC; Gnecco V; Giannattasio J; Hoffman M
    Medicina (B Aires); 1982; 42(4):389-95. PubMed ID: 15171020
    [No Abstract]   [Full Text] [Related]  

  • 2. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bacilliferous tuberculosis and sensitivity of Koch bacilli to tuberculostatic drugs (current situation in a French hospital service)].
    Oudet P
    Arch Monaldi; 1972; 27(4):403-17. PubMed ID: 4217597
    [No Abstract]   [Full Text] [Related]  

  • 4. [Primary drug resistance of tuberculosis mycobacteria].
    Fedotova ZN; Kerpel' RS
    Probl Tuberk; 1971; 49(11):33-7. PubMed ID: 5004856
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effectiveness of ethambutol in chronic pulmonary tuberculosis].
    Golli V; Stefanin E; Chiper P; Stefănescu I; Popescu-Crivina IM; Anghel E; Kosinski E; Daha A; Kosinski M; Floricel N
    Ftiziologia; 1972; 21(5):489-94. PubMed ID: 4632131
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-resistance tuberculosis among the foreign-born in Canada.
    Can Commun Dis Rep; 2005 Feb; 31(4):46-52. PubMed ID: 15712449
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary drug resistant tuberculosis in Puerto Rico.
    Zack MB; Figueroa-Lebrón RE
    Bol Asoc Med P R; 1974 Nov; 65(11):262-6. PubMed ID: 4217187
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemoresistance of mycobacteria in a group of patients with tuberculosis from Mureş county].
    Tarcea M; Toma F; Patraulea M; Nemeş M; Tokés C; Sabău M; Golea C
    Bacteriol Virusol Parazitol Epidemiol; 2007; 52(1-2):29-36. PubMed ID: 18441956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating pyrazinamide mono-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Pérez-Arellano CP; García-Toledo D
    Int J Tuberc Lung Dis; 2013 Sep; 17(9):1244-5. PubMed ID: 23928174
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 11. [Considerations on drug-resistent tuberculosis patients admitted to G. Saint-Bois Hospital during the years 1966 to 1970].
    Piñeyro JA; Bazerque E; Fossemalle JR; Tarallo NH
    Hoja Tisiol; 1971; 28(1-2):77-88. PubMed ID: 5006266
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapy of newly detected cases of pulmonary tuberculosis prior to the results of determining the drug sensitivity of Mycobacterium tuberculosis].
    Rudoĭ NM; Krivenko GT
    Probl Tuberk; 1988; (11):24-8. PubMed ID: 3146752
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparison of drug resistance and blood bacteriostatic activity in patients with pulmonary tuberculosis].
    Kochetov BI; Gur'ian IE
    Probl Tuberk; 1971; 49(6):64-7. PubMed ID: 5000745
    [No Abstract]   [Full Text] [Related]  

  • 14. Antituberculosis drug resistance and associated risk factors in the European section of Turkey.
    Karabay O; Otkun M; Akata F; Karlikaya C; Tuğrul M; Dündar V
    Indian J Chest Dis Allied Sci; 2004; 46(3):171-7. PubMed ID: 15553205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incidence of primary resistance to antitubercular agents in the Toulouse area].
    Puel J; Galtier M; Lareng MB; Delaude A
    Arch Monaldi; 1972; 27(4):418-25. PubMed ID: 4217598
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical aspects of secondary resistance in pulmonary tuberculosis].
    Gugić B
    Plucne Bolesti; 1985; 37(1-2):22-7. PubMed ID: 3934690
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and bacteriological experimentation with a new antitubercular chemotherapeutic agent: ethambutol].
    Serra C; Andreis G
    G Ital Chemioter; 1966; 13(1):109-27. PubMed ID: 4967318
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ethambutol in the treatment of chronic pulmonary tuberculosis with bacilli resistant to tuberculostatics].
    Anastasatu C; Kaufman S; Barcan F; Gheorghiu M; Cristea M; Ulpian C; Iancovici O
    Ftiziologia; 1971; 20(4):373-9. PubMed ID: 5005706
    [No Abstract]   [Full Text] [Related]  

  • 19. [Initial drug resistance as a threat for tuberculosis control: the case of Buenaventura, Colombia].
    Moreira CA; Hernández HL; Arias NL; Castaño MC; Ferro BE; Jaramillos E
    Biomedica; 2004 Jun; 24 Supp 1():73-9. PubMed ID: 15495574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is there a structural identity between sensitive strains of M. tuberculosis isolated from new patients and those from patients in recurrence and relapse following current initial chemotherapy?].
    Bercea O; Diaconescu C; Corlan E; Iacob L; Arjoceanu R; Ispas TL
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1987; 36(3):229-39. PubMed ID: 2831614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.